HYPNOLINE: Contribution of Hypnosis on Image Quality in Cardiac MRI

Sponsor
University Hospital, Bordeaux (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05999578
Collaborator
(none)
90
1
3
20
4.5

Study Details

Study Description

Brief Summary

The present project aims to explore the effect of a hypnosis session performed on a patient with anxiety during a cardiac MRI examination on image quality.

Condition or Disease Intervention/Treatment Phase
  • Other: Hypnosis
N/A

Detailed Description

Cardiac Magnetic Resonance Imaging (MRI) is an activity of the Bordeaux University Hospital that continues to grow (+7.3% in 2021 compared to 2019) under the combined effect of the increase in activity of cardiology care channels and the extension of clinical indications for cardiac MRI. Indeed, cardiac MRI has become an essential examination in the diagnosis of many heart diseases and is little practiced elsewhere in New Aquitaine. The current delay for a cardiac MRI is 3 and a half months.

In this context, it is necessary to be efficient because any procedure failure, examination interruption or insufficient image quality can delay the diagnosis and therapeutic management of the patient for several months. Numerous studies have shown that anxiety induces interruptions in the acquisition of MRI images and repetition of sequences, thus prolonging the examination time.

However, no study takes into account the specificity of cardiac MRI, whose image quality is intimately linked to the patient's cooperation and to the synchronization of the sequences with the heart rhythm.

Hypnosis seems to be adapted to reduce the patient's anxiety, by allowing him to ignore the surrounding reality while remaining in relation with the attendant.

The hypothesis is that by reducing patient anxiety through hypnosis, image quality in cardiac MRI would be improved.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
90 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Evaluating the Contribution of Hypnosis on Image Quality During Cardiac Magnetic Resonance Imaging (MRI) in Anxious Patients
Anticipated Study Start Date :
Sep 1, 2023
Anticipated Primary Completion Date :
May 1, 2025
Anticipated Study Completion Date :
May 1, 2025

Arms and Interventions

Arm Intervention/Treatment
Experimental: Anxious patients with hypnosis

Hypnosis support before, during and at the end of cardiac MRI exam

Other: Hypnosis
Hypnosis support before, during and at the end of cardiac MRI exam

No Intervention: Anxious patients without hypnosis

Cardiac MRI exam accordingly to usual care

No Intervention: Non anxious patients

Cardiac MRI exam accordingly to usual care

Outcome Measures

Primary Outcome Measures

  1. quality of cardiac MRI images [Baseline]

    Likert score measurements

Secondary Outcome Measures

  1. number of artifacts [Baseline]

    The number of artifacts will be estimated with European CMR Registry objective score.

  2. Diagnostic validation score [Baseline]

    The diagnostic validation score for the entire examination (and not sequence by sequence) makes it possible to define whether, despite the presence of artifacts, the examination makes it possible to answer the question initially asked in the examination request.

  3. Causality score measurement [Baseline]

    Causality score measurement for examinations with a Likert score < 4

  4. Overall duration [Baseline]

    The overall duration of the examination and the different phases (reception and preparation time, image acquisition time).

  5. Number of repeated or interrupted sequences [Baseline]

    The number of repeated or interrupted sequences (by the Radiographer or the patient).

  6. Anxiety level [Baseline]

    The Spielberg State Anxiety Index STAI-Y anxiety score will be used to estimate patient anxiety before and after the MRI.

  7. Post-MRI satisfaction score [Baseline]

    The post-MRI satisfaction score will be estimated from the patient by a visual analog scale rated from 0 (not at all satisfied) to 10 (very satisfied).

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Anxious patient (anxiety score TRAIT (baseline) and anxiety score STATE (situational) ≥ 46) and non-anxious patient (anxiety score TRAIT and anxiety score STATE < 46) requiring cardiac MRI for diagnosis or follow-up of a cardiac pathology except the patients with cardiac arrhythmias or irregular heartbeats.

  • 18 years and older

  • Highly effective contraception for women of childbearing potential, maintained during research procedures

  • Informed consent

  • Affiliated or beneficiary of health insurance

Exclusion Criteria:
  • Contraindications to MRI and gadoline contrast medium

  • Hearing impaired patients

  • Patients who do not speak French

  • Women who are pregnant or lactating

  • Inability to agree to participate to the study

  • Patient under legal protection

Contacts and Locations

Locations

Site City State Country Postal Code
1 CHU Bordeaux Bordeaux France

Sponsors and Collaborators

  • University Hospital, Bordeaux

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University Hospital, Bordeaux
ClinicalTrials.gov Identifier:
NCT05999578
Other Study ID Numbers:
  • CHUBX 2022/79
First Posted:
Aug 21, 2023
Last Update Posted:
Aug 21, 2023
Last Verified:
Aug 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University Hospital, Bordeaux

Study Results

No Results Posted as of Aug 21, 2023